Sex and gender dimension in research: Health & Medicine

Online training Sex and gender dimension in research: Health & Medicine
  • 23 March 2021
  • 14:00-17:00 cet (Brussels time)
  • Vera Regitz-Zagrosek
Important information
  • This training focuses on the sex and gender dimension in the research field of Health & Medicine.
Learning objectives
  • Provide an overview on sex and gender dimensions in research with a special focus on health and medicine issues
  • Help to understand the concepts of sex and gender and their relevance for research – focusing health and medicine related topics
  • Sensitize on the importance of including the sex and gender dimension into research projects and designing more gender sensitive projects
  • Identify, understand and recognize the different impacts of sex and gender on health, during different developmental periods, on pathophysiology and manifestation of some frequent diseases, such as cardiovascular, inflammatory and autoimmune, metabolic and endocrine diseases
  • Develop an awareness for sex and gender related issues in pharmacology, pharmacodynamics and drug development
Who is it for?
  • Health administrators in politics, universities and companies
  • Students of life sciences: medicine, psychology, biology, and nursing sciences
  • Practitioners in healthcare sector: nurses, doctors and others Researchers at (healthcare related) universities and private companies
  • Research team leaders
  • Research coordinators at RPOs and RFOs
  • Research officers / research advisors / people in charge of supporting research projects
  • People in charge of the valorisation /dissemination of research outputs
  • Officers at research and transfer support units at universities
Training materials





Vera Regitz-Zagrosek

Professor on Cardiovascular Disease (CVD) in women

Vera Regitz-Zagrosek, obtained a professorship on Cardiovascular Disease (CVD) in women, founded the Working Group on CVD in Women at the German Cardiac Society (DGK) in 2003 and the German and International Society for Gender in Medicine (DGesGM and IGM) in 2007 and coordinated the DFG Research Training Group and DFG Research Unit on “Sex-specific mechanisms of myocardial hypertrophy” (2001-2015). In 2007 she became the founding director of the Berlin Institute for Gender in Medicine, at Charité, University Medicine Berlin. She acted as Task Force Leader for the guidelines on the “Management of Cardiovascular Diseases in Pregnancy” 2018 and review coordinator for the 2021 European Guidelines on CVD prevention in clinical practice of the European Society of Cardiology (ESC). She coordinated BMBF and EU funded projects: Gender and age (2017-2020), “Gender Medicine” (BMBF), EUGIM (European Curriculum in Gender Medicine), EuGenMed (European Gender Medicine) and GenCad EU (Gender in coronary artery disease) and is PI at the European Gender Academy. She is active as reviewer for national and international funding organizations and journals, published more than 200 scientific papers and numerous book chapters, edited two books on gender medicine and pharmacology and organized annual congresses in gender medicine. She received in 2016 the honorary doctorate from the Medical University of Innsbruck, Austria. She held a guest professorship at Medical University Utrecht (NL) and the Anna Fischer Dückelmann guest professorship at the University of Zürich (Switzerland) in 2019. In 2018 She received the “Bundesverdienstkreuz” for her work in gender sensitive medicine by the president of the Federal Republic of Germany.